ORCID as entered in ROS

Select Publications
2023, 'Burden of mental health issues in people with inflammatory bowel disease in Australasia: Crohn's Colitis Cure data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 165 - 165
,2023, 'Cessation of corticosteroids after acute severe ulcerative colitis may be associated with increased colectomy risk: Results of the ANZ-ASUC study in collaboration with the ANZIBDC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 186 - 187
,2023, 'Comparing long-term outcomes in patients with inflammatory bowel disease between switch and non-switch cohorts: No differences in infliximab persistence or safety outcomes after 54 months', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 170 - 170
,2023, 'Comparison of diagnostic modalities for Crohn's disease', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 153 - 154
,2023, 'Key metabolomic alterations are associated with ulcerative colitis disease state and activity', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 108 - 109
,2023, 'Patients from East Asia with acute severe ulcerative colitis have worse endoscopic severity but are more responsive to intravenous steroids than patients from Australasia: Preliminary results of the APAC-ASUC study in collaboration with the ANZIBDC and AOCC', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 190 - 192
,2023, 'Variation of outcomes in inflammatory bowel disease at 10 Australian and New Zealand centers: Crohn's Colitis Cure data insights program', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 168 - 169
,2023, 'Withdrawal vs continuation of thiopurine in vedolizumab-treated patients with ulcerative colitis (VIEWS): A multicenter randomized controlled trial', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 123 - 124
,2022, 'Development and validation of a convolutional neural network model in the detection of Crohn's disease erosions and ulcers by panenteric wireless capsule endoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 173 - 174, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2022, 'Histological remission using a Nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 170 - 170, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700253&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Catastrophe prevention: Acute severe ulcerative colitis', in Journal of Gastroenterology and Hepatology Australia, pp. 34, http://dx.doi.org/10.1111/jgh.15459
,2019, 'Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, pp. 155 - 156, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100242&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,